FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 17248

FusionGeneSummary for IGHG1_RBP4

check button Fusion gene summary
Fusion gene informationFusion gene name: IGHG1_RBP4
Fusion gene ID: 17248
HgeneTgene
Gene symbol

IGHG1

RBP4

Gene ID

3500

5950

Gene nameimmunoglobulin heavy constant gamma 1 (G1m marker)retinol binding protein 4
Synonyms-MCOPCB10|RDCCAS
Cytomap

14q32.33

10q23.33

Type of geneotherprotein-coding
Descriptionconstant region of heavy chain of IgG1immunoglobulin gamma 1 (Gm marker)retinol-binding protein 4PRBPRBPplasma retinol-binding proteinretinol binding protein 4, plasmaretinol-binding protein 4, interstitial
Modification date2018052320180527
UniProtAcc

P01857

P02753

Ensembl transtripts involved in fusion geneENST00000390548, ENST00000371464, 
ENST00000371467, ENST00000371469, 
Fusion gene scores* DoF score43 X 54 X 5=116106 X 4 X 3=72
# samples 596
** MAII scorelog2(59/11610*10)=-4.29850920750373
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/72*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: IGHG1 [Title/Abstract] AND RBP4 [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotation
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneRBP4

GO:0030277

maintenance of gastrointestinal epithelium

10944490

TgeneRBP4

GO:0032526

response to retinoic acid

571335

TgeneRBP4

GO:0042593

glucose homeostasis

17003346


check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
TCGALDLIHCTCGA-FV-A4ZQ-01AIGHG1chr14

106208402

-RBP4chr10

95360728

-
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
intron-3CDSENST00000390548ENST00000371464IGHG1chr14

106208402

-RBP4chr10

95360728

-
intron-3CDSENST00000390548ENST00000371467IGHG1chr14

106208402

-RBP4chr10

95360728

-
intron-3CDSENST00000390548ENST00000371469IGHG1chr14

106208402

-RBP4chr10

95360728

-

Top

FusionProtFeatures for IGHG1_RBP4


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
IGHG1

P01857

RBP4

P02753

Constant region of immunoglobulin heavy chains.Immunoglobulins, also known as antibodies, are membrane-bound orsecreted glycoproteins produced by B lymphocytes. In therecognition phase of humoral immunity, the membrane-boundimmunoglobulins serve as receptors which, upon binding of aspecific antigen, trigger the clonal expansion and differentiationof B lymphocytes into immunoglobulins-secreting plasma cells.Secreted immunoglobulins mediate the effector phase of humoralimmunity, which results in the elimination of bound antigens(PubMed:22158414, PubMed:20176268). The antigen binding site isformed by the variable domain of one heavy chain, together withthat of its associated light chain. Thus, each immunoglobulin hastwo antigen binding sites with remarkable affinity for aparticular antigen. The variable domains are assembled by aprocess called V-(D)-J rearrangement and can then be subjected tosomatic hypermutations which, after exposure to antigen andselection, allow affinity maturation for a particular antigen(PubMed:17576170, PubMed:20176268). {ECO:0000303|PubMed:17576170,ECO:0000303|PubMed:20176268, ECO:0000303|PubMed:22158414}. Retinol-binding protein that mediates retinol transportin blood plasma (PubMed:5541771). Delivers retinol from the liverstores to the peripheral tissues (Probable). Transfers the boundall-trans retinol to STRA6, that then facilitates retinoltransport across the cell membrane (PubMed:22665496).{ECO:0000269|PubMed:22665496, ECO:0000305,ECO:0000305|PubMed:5541771}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for IGHG1_RBP4


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.

* Fusion transcript sequences (only coding sequence (CDS) region).

* Fusion transcript sequences (Full-length transcript).

Top

FusionGenePPI for IGHG1_RBP4


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors
IGHG1FCGR3B, UCHL5, TRIM21, SHC1, ALB, VCAM1, PHB, EGFR, YWHAE, IQCB1, PARK2, CUL7, OBSL1, EED, SUSD3, HSD17B10, CA8, GDPD1, FAM175B, ASCC1, DDX19B, AGA, CCDC51, TFG, UGT1A10, ICE2, ZSCAN20, ALDH2, RBM24, MCM2, PDE4DIP, CDK15, CYP3A5, DDX31, ZNF354C, ALDH3A1, SNX27, TBC1D22B, CYLD, TRIM25RBP4TTR, GRB2, RBBP6, LAMTOR5, FTH1, MSRB3, MARCKSL1, CRYBA4, MTO1, TMEM205, HESX1, POLR3D, KLHL24


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for IGHG1_RBP4


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
TgeneRBP4P02753DB00755TretinoinRetinol-binding protein 4small moleculeapproved|investigational|nutraceutical

Top

RelatedDiseases for IGHG1_RBP4


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneIGHG1C0027121Myositis1CTD_human
HgeneIGHG1C0032460Polycystic Ovary Syndrome1CTD_human
TgeneRBP4C3554593RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME2ORPHANET;UNIPROT
TgeneRBP4C0000786Spontaneous abortion1CTD_human
TgeneRBP4C0018801Heart failure1CTD_human
TgeneRBP4C0022658Kidney Diseases1CTD_human
TgeneRBP4C0023896Alcoholic Liver Diseases1CTD_human
TgeneRBP4C0024667Animal Mammary Neoplasms1CTD_human
TgeneRBP4C0024668Mammary Neoplasms, Experimental1CTD_human
TgeneRBP4C0027540Necrosis1CTD_human
TgeneRBP4C0032460Polycystic Ovary Syndrome1CTD_human
TgeneRBP4C0038356Stomach Neoplasms1CTD_human
TgeneRBP4C0042842Vitamin A Deficiency1CTD_human
TgeneRBP4C0152455Keratomalacia1CTD_human
TgeneRBP4C4225330MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 101UNIPROT